Zealand Pharma A/S. Profit Margin

The latest profit margin for ZEAL is -497.08% as of March 2022. That compares with -239.68% in the prior-year period — down 107.4% year over year. That is below the Healthcare sector average of 13.45%. Investors often review this figure alongside Zealand Pharma A/S.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ZEAL's profit margin moved from -239.68% to -497.08% — a 107.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zealand Pharma A/S.'s valuation or profitability profile.

Against Healthcare companies, ZEAL currently prints -497.08% for profit margin, while the sector average sits near 13.45%. That is roughly 3796.3% below the sector mean. Large gaps often invite a closer look at Zealand Pharma A/S.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Zealand Pharma A/S. converts resources into returns. At -497.08%, ZEAL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -239.68% in the prior-year period — down 107.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZEAL's profit margin (-497.08%), review year-over-year change from -239.68%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.